Latest Publications
Explore our most recent scientific milestones, peer-reviewed insights, and the impact Unicorn Biotechnologies is making in the life sciences space.
Patellofemoral Arthritis Treatment Options: The Kneecap-Specific Decision Framework That Separates PFA from Generic Knee OA Protocols
Patellofemoral arthritis affects up to 24% of women over 55, yet most patients receive generic knee pain protocols that miss the mark. This guide presents a condition-specific decision framework mapping treatment to disease severity and alignment status. Learn how to distinguish PFA from general knee osteoarthritis and explore targeted options from conservative care to advanced cellular therapies.
Biceps Tendonitis PRP Injection: The Co-Pathology Framework That Determines Whether PRP Will Actually Work for Your Long Head Biceps
PRP injection for biceps tendonitis shows 60–80% success rates in clinical literature, but undiagnosed co-pathology remains the leading reason treatment fails. This guide introduces a structured co-pathology audit framework to help you determine whether you're the right candidate. Learn what diagnostic workup is essential before committing to treatment.
PRP Preparation Methods Comparison: The Variable-Stack Framework That Explains Why Identical Diagnoses Get Different Outcomes
Two patients with the same diagnosis receive PRP therapy and get completely opposite results—why? This in-depth PRP preparation methods comparison introduces the variable-stack framework, explaining how five interdependent preparation factors compound to determine clinical outcomes. Learn how to match the right configuration to your diagnosis using tools like PAW and DEPA.
Infraspinatus Tendonitis Cellular Therapy: The Posterior Rotator Cuff Protocol That Treats What Generic Shoulder Injections Miss
Infraspinatus tendonitis is routinely misdiagnosed and undertreated by generic rotator cuff protocols. This guide introduces a posterior cuff differentiation matrix that matches your specific symptom profile to the right cellular therapy—whether PRP, BMAC, or exosomes—for lasting relief rather than short-term symptom masking.
Bone Marrow Harvest Site Pain: The 48-Hour Peak-to-Resolution Timeline Most Clinics Never Show You
Most clinics describe bone marrow harvest site pain as mere 'temporary discomfort'—leaving patients unprepared for what actually lies ahead. This guide reveals the clinically backed, hour-by-hour recovery timeline showing pain peaks at 48 hours and resolves in 89% of patients by 3 months. Know exactly what to expect, when to act, and how to recover with confidence.
Exosome Therapy Research 2026: The Clinical Trial Pipeline Map That Separates Hype from Regulatory Reality
Zero FDA-approved exosome products exist in 2026, yet a $58.1 billion market valuation and 557% surge in consumer interest tell a more complex story. This evidence-based guide maps the clinical trial pipeline, examines the Capricor BLA as a bellwether event, and equips patients and clinicians with a practical framework for evaluating real scientific progress. Discover where exosome therapy genuinely stands on the approval continuum.
